PROCTER & GAMBLE HEALTH | INDOCO REMEDIES | PROCTER & GAMBLE HEALTH/ INDOCO REMEDIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 30.0 | 115.1% | View Chart |
P/BV | x | 10.6 | 2.9 | 358.1% | View Chart |
Dividend Yield | % | 2.0 | 0.7 | 293.6% |
PROCTER & GAMBLE HEALTH INDOCO REMEDIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
INDOCO REMEDIES Mar-23 |
PROCTER & GAMBLE HEALTH/ INDOCO REMEDIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 423 | 1,268.2% | |
Low | Rs | 3,883 | 308 | 1,260.9% | |
Sales per share (Unadj.) | Rs | 740.7 | 181.1 | 409.1% | |
Earnings per share (Unadj.) | Rs | 138.2 | 15.4 | 895.5% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 23.1 | 671.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.25 | 4,222.2% | |
Avg Dividend yield | % | 2.1 | 0.6 | 333.7% | |
Book value per share (Unadj.) | Rs | 447.6 | 111.5 | 401.4% | |
Shares outstanding (eoy) | m | 16.60 | 92.15 | 18.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.0 | 309.2% | |
Avg P/E ratio | x | 33.5 | 23.7 | 141.3% | |
P/CF ratio (eoy) | x | 29.8 | 15.8 | 188.3% | |
Price / Book Value ratio | x | 10.3 | 3.3 | 315.2% | |
Dividend payout | % | 68.7 | 14.6 | 471.5% | |
Avg Mkt Cap | Rs m | 76,761 | 33,683 | 227.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 3,226 | 63.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 16,686 | 73.7% | |
Other income | Rs m | 184 | 24 | 771.4% | |
Total revenues | Rs m | 12,480 | 16,710 | 74.7% | |
Gross profit | Rs m | 3,247 | 2,860 | 113.5% | |
Depreciation | Rs m | 281 | 706 | 39.8% | |
Interest | Rs m | 8 | 250 | 3.1% | |
Profit before tax | Rs m | 3,142 | 1,928 | 163.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 505 | 167.6% | |
Profit after tax | Rs m | 2,295 | 1,423 | 161.3% | |
Gross profit margin | % | 26.4 | 17.1 | 154.0% | |
Effective tax rate | % | 27.0 | 26.2 | 102.9% | |
Net profit margin | % | 18.7 | 8.5 | 218.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 8,082 | 144.9% | |
Current liabilities | Rs m | 6,791 | 4,245 | 160.0% | |
Net working cap to sales | % | 40.0 | 23.0 | 174.1% | |
Current ratio | x | 1.7 | 1.9 | 90.6% | |
Inventory Days | Days | 263 | 25 | 1,047.6% | |
Debtors Days | Days | 343 | 768 | 44.7% | |
Net fixed assets | Rs m | 10,617 | 9,055 | 117.2% | |
Share capital | Rs m | 166 | 184 | 90.1% | |
"Free" reserves | Rs m | 7,265 | 10,092 | 72.0% | |
Net worth | Rs m | 7,431 | 10,276 | 72.3% | |
Long term debt | Rs m | 0 | 1,435 | 0.0% | |
Total assets | Rs m | 22,330 | 17,137 | 130.3% | |
Interest coverage | x | 409.1 | 8.7 | 4,700.2% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.0 | 56.6% | |
Return on assets | % | 10.3 | 9.8 | 105.6% | |
Return on equity | % | 30.9 | 13.8 | 223.1% | |
Return on capital | % | 42.4 | 18.6 | 227.9% | |
Exports to sales | % | 0 | 47.5 | 0.0% | |
Imports to sales | % | 13.1 | 11.5 | 113.6% | |
Exports (fob) | Rs m | NA | 7,919 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 1,917 | 83.7% | |
Fx inflow | Rs m | 1,465 | 7,919 | 18.5% | |
Fx outflow | Rs m | 1,605 | 1,917 | 83.7% | |
Net fx | Rs m | -140 | 6,002 | -2.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 1,788 | 132.0% | |
From Investments | Rs m | -215 | -2,082 | 10.3% | |
From Financial Activity | Rs m | -985 | 228 | -431.8% | |
Net Cashflow | Rs m | 1,160 | -65 | -1,776.6% |
Indian Promoters | % | 0.0 | 58.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 21.3 | 93.6% | |
FIIs | % | 6.2 | 1.9 | 325.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 41.3 | 116.7% | |
Shareholders | 56,778 | 33,201 | 171.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Indoco Remedies | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 1.11% | 0.45% |
1-Month | -1.15% | -0.95% | 2.55% |
1-Year | 0.73% | 5.63% | 56.14% |
3-Year CAGR | -8.76% | -0.35% | 15.22% |
5-Year CAGR | 4.97% | 10.16% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Indoco Remedies share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Indoco Remedies the stake stands at 58.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Indoco Remedies.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Indoco Remedies paid Rs 2.3, and its dividend payout ratio stood at 14.6%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Indoco Remedies.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.